Advertisement
Advertisement
U.S. Markets open in 4 hrs 13 mins
Advertisement
Advertisement
Advertisement
Advertisement

Herborium Group, Inc. (HBRM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00030.0000 (0.00%)
At close: 03:54PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0003
Open0.0003
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0002 - 0.0003
52 Week Range0.0002 - 0.0020
Volume7,120,122
Avg. Volume44,113,182
Market Cap550,737
Beta (5Y Monthly)118.03
PE Ratio (TTM)0.00
EPS (TTM)0.1150
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Herborium® Enters $220Billion Digital Content Market

    The First Stage of Transition Into the “Content Plus Product” Entity To Be Deployed in Fourth Quarter of 2022Houston, May 10, 2022 (GLOBE NEWSWIRE) -- Houston, Texas, 05/10/2022. Herborium Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicinal, beauty and wellness products with a clinically validated records of efficacy and safety, announced today that it officially commenced its transition into “Content Plus Product Company” initially

  • GlobeNewswire

    Herborium® Surpasses Million Dollar Sales Mark; Reduces Outstanding Debt and Dilution

    Houston , Texas, May 03, 2022 (GLOBE NEWSWIRE) -- Houston, Texas,05.03/ 2022. Herborium Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicinal, beauty and wellness products with a clinically validated records of efficacy and safety, announced today that the Company ended 2021 with a record sale surpassing $1Million as reported in Annual Report . 2021. This marks the fifth consecutive Positive Revenues Year . This positive trend is exten

  • GlobeNewswire

    Herborium® Group Inc, Shareholder Update Letter

    Monetizing 2022 OpportunitiesHouston, Feb. 28, 2022 (GLOBE NEWSWIRE) -- February 28, 2022. Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, www.acnease.com a Botanical Therapeutics® Company and the provider of proprietary all botanical medicinal products (Botanical Therapeutics®) and interactive advanced content targeting dermatological and other health and wellness concerns, shares a Shareholders Update Letter from the CEO, Dr. Agnes Olszewski. To our Valued ShareholdersThe times are

Advertisement
Advertisement